Levi Strauss stock falls
Levi Strauss Is Proof That Denim Is As Fashionable As Ever
Levi Strauss & Co (NYSE: LEVI) issued a mixed quarterly report. While the iconic denim brand is doing great as far as its namesake brand and Beyond Yoga are concerned, but its Dockers business is another story,
Levi Strauss: Sales Still Challenged Despite Denim Cycle, Stock Remains Expensive
Levi Strauss & Co.'s Q3 2024 results were disappointing, with flat earnings and downward revised guidance. Learn more about LEVI stock here.
3-Stock Lunch: Nvidia, Levi Strauss & Co & Hims & Hers Health Inc
Fox News' Bryan Llenas reports from the picket line at Red Hook Terminal in New York on the union's demands and impact of the strike. Quint Tatro, Joule FInancial president, joins 'Power Lunch' to discuss stock plays for three stocks.
What’s Causing Levi Strauss & Co (LEVI) Stock’s 12.86% Jump Over the Last Six Months?
On Wednesday, Levi Strauss & Co (LEVI) stock saw a decline, ending the day at $21.06 which represents a decrease of $-0.62 or -2.86% from the prior close of $21.68. The stock opened at $21.51 and touched a low of $20.
Levi Strauss Stock Plunges as Company Considers Selling Dockers Brand
Key Takeaways Shares of Levi Strauss tumbled in early trading Thursday after the jeans maker announced it may sell its Dockers brand as it delivered mixed third-quarter results.While Levi's adjusted earnings per share of 33 cents beat consensus Wall Street estimates,
Levi Strauss’ Stock Falls 12% On Weak Guidance, Plan To Sell Dockers Brand
The stock of Levi Strauss & Co. (LEVI) is down 12% after the retailer reported mixed financial results, lowered its guidance, and announced plans to sell its Dockers brand. The San Francisco-based company that’s known for its blue jeans reported
Levi Strauss stock falls, as new campaign with Beyoncé outweighed by subdued sales forecast
Shares of Levi Strauss & Co. slid after hours on Wednesday after the jeans maker tempered its full-year sales forecast, even as management said its core Levi’s brand was leading the way toward improvement and called out potential gains from its new partnership with Beyoncé.
Levi Strauss' Q3 Results Are Not Appreciated By The Market
Levi Strauss & Co. faces challenges with disappointing revenue and declining Dockers sales. Learn more about LEVI stock and ...
Levi Strauss & Co: Balancing Robust Profit Growth with Conservative Outlook and Mixed Regional Performance
J.P. Morgan analyst Matthew Boss maintained a Hold rating on Levi Strauss & Co (LEVI – Research Report) yesterday and set a price ...
Money Morning20h
Three Stocks: Constellation Brands, Levi's and Valero
Levi's maintains a bullish outlook with a price target of $23. Constellation Brands ( STZ) are trading lower today after the ...
Levi Strauss & Co (LEVI) Q3 2024 Earnings Call Transcript Highlights: Record Gross Margins ...
Levi Strauss & Co (LEVI) reports strong brand growth and profitability, while exploring strategic alternatives for Dockers ...
Levi Strauss & Co.: Resilient DTC Sales Amid Mixed Financial Outcomes and a Hold Rating
Bank of America Securities analyst Christopher Nardone reiterated a Hold rating on Levi Strauss & Co (LEVI – Research Report) today ...
Levi Strauss & Co. shares stumble, and other early movers
Hims & Hers Health shares are slipping more than 8% after the Food and Drug Administration said there were no longer shortages of Eli Lilly’s obesity and diabetes drugs Zepbound and Mounjaro.
Analyst Scoreboard: 6 Ratings For Levi Strauss
Analysts have set 12-month price targets for Levi Strauss, revealing an average target of $24.33, a high estimate of $26.00, ...